Answers are grounded in this paper and cite their sources.
This research develops a pH-responsive polymeric intervention that disrupts cancer cells without drugs, indicating potential for new therapies.
Molecular blocks (MBs) offer a drug‐free approach to cancer therapy by utilizing polymeric nanoparticles that remain dispersed in the bloodstream but aggregate within the acidic tumor microenvironment (pH 6.3–6.5) to disrupt cancer cell membranes. Herein, a pH‐responsive polymeric MB is developed by conjugating deoxycholic acid (DCA) to chitosan (CS) through a water‐based modification using CS succinate (CS‐S). The resulting CS‐S–DCA nanoparticles exhibit significant aggregation at pH 6.2 while maintaining a smaller size at physiological pH (7.4), demonstrating pH‐triggered behavior. This leads to selective cytotoxicity against cancer cell lines (MiaPaCa‐2, A‐549, and HT‐29) while preserving compatibility with normal human dermal fibroblasts. Fluorescence imaging confirms preferential adhesion of CS‐S–DCA to cancer cells over normal cells. Encouraged by these findings, in vivo studies in a mouse model are conducted, which reveal significant tumor suppression without the use of conventional drugs. This work highlights the potential of concerted pH‐responsive polymeric MBs as a promising and biocompatible strategy for drug‐free cancer therapy.
No takes yet. Share an insight, caveat, or question.
Thanongsak et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: